We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

July 13, 2009

Allergan Inc. et al v. Watson Laboratories, Inc.-Florida

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. April 3, 2012

    Judge Rules Allergan's Sanctura XR Patents Invalid

    Allergan Inc. suffered a blow on Saturday when a Delaware federal judge ruled three patents covering the drugmaker's overactive bladder drug Sanctura XR were invalid, finding prior art rendered the patents' claims obvious.


To view the parties, register now.